Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
6.70
-0.15 (-2.19%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Fennec Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
231263174303252114
Upgrade
Market Cap Growth
67.14%51.48%-42.68%20.14%120.31%-40.49%
Upgrade
Enterprise Value
19426016531624795
Upgrade
Last Close Price
6.707.706.3211.229.604.40
Upgrade
Forward PE
54.0315.88-90.85--
Upgrade
PS Ratio
5.175.893.6514.25164.24-
Upgrade
PB Ratio
6.457.41-29.57-26.06-98.137.26
Upgrade
P/TBV Ratio
6.517.41---7.26
Upgrade
P/OCF Ratio
--6.44---
Upgrade
EV/Sales Ratio
4.355.833.4814.88160.94-
Upgrade
EV/EBITDA Ratio
--45.94---
Upgrade
EV/EBIT Ratio
--64.41---
Upgrade
Debt / Equity Ratio
---3.29-2.66-9.690.32
Upgrade
Debt / EBITDA Ratio
--5.37---
Upgrade
Net Debt / Equity Ratio
-1.04-1.041.24-1.52-0.44-1.02
Upgrade
Net Debt / EBITDA Ratio
5.955.95-2.03---
Upgrade
Asset Turnover
0.770.771.320.790.06-
Upgrade
Inventory Turnover
2.872.871.980.92--
Upgrade
Quick Ratio
5.715.715.712.925.4912.76
Upgrade
Current Ratio
6.376.376.383.565.8013.54
Upgrade
Return on Equity (ROE)
-65.82%-65.82%---359.22%-77.36%
Upgrade
Return on Assets (ROA)
-6.80%-6.80%4.47%-29.67%-57.21%-39.99%
Upgrade
Return on Capital Employed (ROCE)
-10.50%-10.50%6.80%-66.10%-101.20%-83.00%
Upgrade
Earnings Yield
-4.22%-3.70%-0.25%-5.30%-9.41%-15.16%
Upgrade
Buyback Yield / Dilution
-4.70%-4.70%-2.71%-1.14%-1.03%-9.71%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.